Edelweiss Life Insurance gets IRDAI warning, barred from opening new offices for 6 months

Edelweiss Life Insurance gets IRDAI warning, barred from opening new offices for 6 months


Edelweiss Financial Services Ltd on Friday (August 21) said its subsidiary Edelweiss Life Insurance Company Ltd (ELI) has received a warning from the Insurance Regulatory and Development Authority of India (IRDAI) for non-compliance with the IRDAI (Expenses of Management, including commission of Insurers) Regulations, 2024.

“…we would like to inform you that the Insurance Regulatory and Development Authority of India (IRDAI), vide Order dated August 20, 2026, has issued a warning to Edelweiss Life Insurance Company Limited (ELI), a subsidiary of the Company, for non-compliance with the provisions of the IRDAI (Expenses of Management, including commission of Insurers) Regulations, 2024, for the financial year ended March 31, 2025,” according to a stock exchange filing.

The order was issued on August 20, 2026, and relates to the financial year ended March 31, 2025. As part of the order, IRDAI has directed ELI not to open any new place of business for six months from the date of the order.

ALSO READ | Edelweiss Financial Services shares gain 7% post positive Q3 results, revenue rises to ₹4,404 crore

Edelweiss Financial Services said the order will have no material impact on the financials, operations or other activities of ELI, the company or its other subsidiaries.

In June this year, Edelweiss Financial Services Ltd had launched a public issue of secured redeemable non-convertible debentures (NCDs) with a base issue size of ₹150 crore and a green shoe option of up to ₹150 crore, taking the total issue size to ₹300 crore.

The NCD issue opened on June 8 and is scheduled to close on June 19, with the company reserving the right to close the issue earlier or extend the closing date, subject to regulatory approvals.

ALSO READ | Rashesh Shah raises stake in Edelweiss Financial Services to 17.5% with 1 crore share purchase

The issue comprises 10 series of NCDs with tenures of 24 months, 36 months, 60 months and 120 months. Investors can choose from annual, monthly and cumulative interest payment options. According to the company, the effective annual yield on the instruments ranges between 8.64% and 10%.

The NCDs have a face value of ₹1,000 each and will be issued and traded only in dematerialised form. The allotment of NCDs will be made on the basis of the date of upload of applications into the electronic book of BSE. In case of oversubscription on any day, allotment will be made on a proportionate basis in consultation with the stock exchange.EFSL said at least 75% of the proceeds from the issue will be utilised for repayment or prepayment of interest and principal on existing borrowings, while the remaining funds will be used for general corporate purposes. The allocation towards general corporate purposes will not exceed 25% of the amount raised.

ALSO READ | Edelweiss MF’s Altiva Hybrid Long-Short SIF raises ₹320 crore in maiden subscription

The proposed NCDs have been assigned a rating of “CRISIL A+/Stable” by CRISIL Ratings, indicating an adequate degree of safety regarding timely servicing of financial obligations.

The NCDs are proposed to be listed on the BSE to provide liquidity to investors. Trust Investment Advisors Pvt Ltd, Nuvama Wealth Management Ltd and Tipsons Consultancy Services Pvt Ltd are acting as lead managers to the issue.

Shares of Edelweiss Financial Services Ltd ended at ₹129.50, up by ₹2.90, or 2.29%, on the BSE.

ALSO READ | RBI cancels registration of 35 NBFCs, accepts surrender from 16 others



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *